Santacana, Eugènia <br/><br/>
Predictors of Infliximab Trough Concentrations in Inflammatory Bowel Disease Patients Using a Repeated-Measures Design.  [electronic resource] 

 -  Therapeutic drug monitoring  02 2020 
 - 102-110 p.  digital 
<br/><br/> Publication Type: Journal Article; Observational Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1536-3694 
<br/><br/><label>Standard No.: </label>10.1097/FTD.0000000000000669  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Area Under Curve<br/>Drug Monitoring--methods<br/>Drug Therapy, Combination<br/>Female<br/>Gastrointestinal Agents--administration & dosage<br/>Half-Life<br/>Humans<br/>Immunosuppressive Agents--therapeutic use<br/>Inflammatory Bowel Diseases--drug therapy<br/>Infliximab--administration & dosage<br/>Male<br/>Middle Aged<br/>Models, Biological<br/>Prospective Studies<br/>Serum Albumin